Authors' reply: Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer [7]

British Journal of Surgery

Volumn 94, Issue 1, 2007, Pages 121-122

  Tilanus Linthorst, M M A ^a   Brekelmans, C T M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; CANCER INCIDENCE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; FAMILIAL DISEASE; GENE MUTATION; HUMAN; LETTER; MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION;

EID: 33846452860     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5744     Document Type: Letter

References (2)

1. Brekelmans CTM, Seynaeve C, Menke-Pluymers M, Bruggenwirth HT, Tilanus-Linthorst MMA, Bartels CCM et al. Survival and prognostic factors in BRCA1-associated breast cancer. Ann Oncol 2006; 17: 391-400.
2. v Sprundel TC, Schmidt MK, Rookus MA, Brohet R, van Asperen CJ, Rutgers EJ et al. Risk reduction of contralateral cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br J Cancer 2005; 93: 287-292.